The Latest Workflows for Gene Therapy and Vaccine Analysis

During this webinar, you will understand how capillary electrophoresis (CE) and LC-MS are being used to ensure vaccine and cell and gene therapy product quality. We will discuss how LC-MS is being used to identify impurities present in lipid nanoparticle (LNP) vaccines that have been found to deactivate mRNA. We will also cover how CE is being used in viral vector production to ensure product quality.

Attend this webinar to:

• Understand how LC-MS can detect low level impurities in ionizable lipids used in LNP manufacturing
• Find out how CE is being used to rapidly assess mRNA quality using a multicapillary system
• Discover how LC-MS and CE are providing more information on viral particles to improve their effectiveness in the delivery of mRNA

Presenter: Dr. Steve Lock (Senior Marketing and Market Development Manager, Biopharma, SCIEX)